Akcea Therapeutics, Inc. Purchase Obligation
Akcea Therapeutics, Inc. had Purchase Obligation of $1.10 million as of 2020-06-30, per its 10-Q filed 2020-08-05.
Discontinued › Notes › Commitment and Contingencies › Purchase Obligation, Fiscal Year Maturity
us-gaap:PurchaseObligation · last filed 2020-08-05
- 2020-06-30: Purchase Obligation $1.10M.
- 2020-03-31: Purchase Obligation $900.00K.
- 2019-12-31: Purchase Obligation $4.30M.
- 2019-09-30: Purchase Obligation $7.10M.
| Period end | Purchase Obligation |
|---|---|
| 2020-06-30 | $1.10M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $900.00K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $4.30M 10-K · filed 2020-03-02 |
| 2019-09-30 | $7.10M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $6.60M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $7.17M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $5.03M 10-K · filed 2019-03-01 |